Our Health and Safety initiative - BE SAFE
We strive to keep our employees in good health, supporting their well-being across all working environments. Learn about our BE SAFE initiative.
Search
COVID-19 Volunteering in the U.S.
BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Looking behind the scenes of Afrika Kommt!
Since inception in 2008, Afrika Kommt! has upskilled over 156 young professionals from Sub-Saharan Africa. Learn more about this programme here.
Data Privacy App
Data privacy and security is a serious matter for ourselves and our audience. Click here to read our full data privacy statement for our app.
World Water Day: Good Health Hinges on Good Water
Water availability and quality affects many aspects of individual, societal and environmental health. Good health hinges on good water. Learn more here.
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”. Find out more here.
World Patient Safety Day 2021
As a sign of support for World Patient Safety Day, Boehringer Ingelheim lights up buildings in orange. Click here to learn and find out more.
Professor Gregory Lip introduces the GLORIA™-AF Registry
In this video, Prof. Gregory Lip introduces the GLORIA™-AF Registry Program. Click here to watch the video and to learn more about the program.
MORE GREEN: Environmental sustainability at a glance
On Earth Day, we share the progress of our global environmental sustainability MORE GREEN program and what the team is tackling, all 365 days of the year.
Dr. V. Mohan Releases 9-point Action for People with Diabetes
Dr V. Mohan has released a 9-point action plan to ensure health for people with diabetes. Click here to read the press release and find out more.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India. Click here to find out and learn more.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
Boehringer Ingelheim announces appointment of Vani Manja as India Country MD
Boehringer Ingelheim has announced that Vani Manja is appointed Country Managing Director for India. Read the press release here and find out more.
Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™
Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™. Click here to read the press release and find out more.
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine. Click here to find out and learn more information.
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.
Corporate Social Responsibility
Boehringer Ingelheim is driven by a purpose to positively impact the lives of communities in India. Click here to learn more about our work in this area.
Our FOCUS
Here we look at the importance of knowing your source when purchasing medicines to protect yourself. Click here to learn more about what you can do.
404 page
404
Animal Health Products
Click here to view an overview of our animal health products here. We provide a wide range of products to help improve the lives of animals.
General terms and Conditions
General terms and Conditions
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state